Pharma Focus Asia
KP - Sustainable Packaging Solutions

Novasep Invests US$30 million to Build Viral Vector Production Facility


Novasep announced a strategic investment of US$30 million for a commercial scale production facility of viral vectors.


The new facility will be built at Novasep in Seneffe, Belgium to complement the existing lab-scale suites of the neighbouring site in Gosselies.

The site will feature two cGMP suites on 2000 sqm equipped with a set of single-use bioreactors ranging from 200L up to 2000L. It will fit perfectly with the production requirements for phase III and commercial stages.

To make each project specific, many types of viral vectors are currently being developed. The plant is a response to the strong market demand driven by both a growing interest in this therapeutic approach and a maturing clinical pipeline.

The viral vectors are used in gene therapies or immunotherapies such as new cancer treatment strategies and in new generation therapeutic vaccines.

Nearly 300 products in clinical studies and 9 products are launched into the market by the facility.

The therapeutic approach consists in using the ability of a virus to introduce the genetic material into the host cell. With viral vectors, the genetic material is modified in order to repair the host cell. Typical viral vectors are Lentiviruses, Adenoviruses, and Adeno-associated viruses.

These innovative therapies require targeted technologies for their production.


Estimated CostUS$30 million
Parties InvolvedNovasep
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?